NanoEntek, Inc. (039860.KQ)

3,540.00 -10.00 (-0.28%) As of 10:08AM KST. Market open.

NanoEntek, Inc.

5, Digital-ro 26-gil
12th Floor Guro-gu
Seoul 08389
South Korea
82 2 6220 7728
https://www.nanoentek.com

Sector(s): 
Industry: 
Full-time employees: 131

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Jin-Hyung Park	Chief Executive Officer and Director	N/A	N/A	1967
Mr. Jung-Goo Seo	Vice-President and Director	N/A	N/A	1962

Amounts are as of 31 December 2012, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in KRW.

Description

NanoEntek, Inc. engages in the research and development, production, and sale of life-science lab equipment, in vitro diagnostic medical devices, point of care diagnostic devices, and related consumables and solutions in Korea and internationally. It provides FREND system, a fluorescence immunoassay analyzer; BUDDI, a rapid diagnostic test analyzer; rapid diagnostic test items; ADAM-rWBC, a residual white blood cell counters; ADAMII/fluorescence stem cell counter; fluorescence cell counters and cell analyzers; brightfield cell counters; somatic cell counters; live-cell imaging system; and disposable hemocytometers. The company was founded in 1987 and is headquartered in Seoul, South Korea.

Corporate governance

NanoEntek, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.